Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

TWD 29.1

(0.0%)

Market Cap (In TWD)

5.27 Billion

Revenue (In TWD)

2.96 Billion

Net Income (In TWD)

375.17 Million

Avg. Volume

605.52 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
28.6-36.296295
PE
-
EPS
-
Beta Value
0.666
ISIN
TW0001734002
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Zhiwen Li
Employee Count
-
Website
https://www.sinphar.com.tw
Ipo Date
2002-08-27
Details
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods; and OEM services, such as product design, manufacturing, etc. to manufacturers. The company was founded in 1977 and is headquartered in Yilan City, Taiwan.